Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection.

Citation data:

The Journal of antimicrobial chemotherapy, ISSN: 1460-2091, Vol: 72, Issue: 2, Page: 522-528

Publication Year:
2017
Usage 78
Abstract Views 64
Link-outs 14
Captures 5
Exports-Saves 4
Readers 1
Social Media 1
Tweets 1
PMID:
27999027
DOI:
10.1093/jac/dkw499
Author(s):
Staley, Christopher, Vaughn, Byron P, Graiziger, Carolyn T, Sadowsky, Michael J, Khoruts, Alexander
Publisher(s):
Oxford University Press (OUP)
Tags:
Pharmacology, Toxicology and Pharmaceutics, Medicine
Most Recent Tweet View All Tweets
article description
Recipients of faecal microbiota transplantation (FMT) in treatment of recurrent Clostridium difficile infection (RCDI) remain at markedly increased risk of re-infection with C. difficile with new antibiotic provocations. Urinary tract infections (UTIs) are common indications for antibiotics in these patients, often resulting in C. difficile re-infection.

This article has 0 Wikipedia mention.